Xentria, Inc.
Clinical trials sponsored by Xentria, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new infusion drug tame lung inflammation and cut steroid use? Results expected Nov 2026 (estimated)
- Can a new fertility drug match the real thing? Results expected Mar 2027 (estimated)
-
Experimental drug aims to improve breathing in lung sarcoidosis
Disease control Not yet recruitingThis study tests an investigational drug called XTMAB-16 in people with pulmonary sarcoidosis, a condition that causes inflammation and scarring in the lungs. The trial aims to see if the drug can improve lung function (measured by forced vital capacity) and quality of life. Part…
Phase 2 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a new fertility drug match the real thing?
Disease control Not yet recruitingThis trial tests whether an experimental drug called KM04 is absorbed and cleared by the body in the same way as the approved fertility drug Gonal-f. Healthy adult women aged 18 to 40 receive a single dose of each drug in random order, with blood samples taken to compare drug lev…
Phase 1 • Sponsor: Xentria, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC